ABBV
AbbVie Inc.
Stock
$263.29−2.99 (−1.12%)Close Sep 29, 2026
| Total assets (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $135.1B | −1.5% | −2.3% | 9.7% |
| Total assets (Q2 2026) | $135.1B |
|---|---|
| YoY | −1.5% |
| 5-year CAGR | −2.3% |
| 10-year CAGR | 9.7% |
Total assets
| Period | Total assets | YoY |
|---|---|---|
| 2025 | $134.0B | −0.9% |
| 2024 | $135.2B | +0.3% |
| 2023 | $134.7B | −2.9% |
| 2022 | $138.8B | −5.3% |
| 2021 | $146.5B | −2.7% |
| 2020 | $150.6B | +69.0% |
| 2019 | $89.1B | +50.1% |
| 2018 | $59.4B | −16.2% |
| 2017 | $70.8B | +7.1% |
| 2016 | $66.1B | +24.6% |
| 2015 | $53.1B | +92.8% |
| 2014 | $27.5B | −5.8% |
| 2013 | $29.2B | +8.1% |
| 2012 | $27.0B | — |